![Cell Source Inc (QB)](/common/images/company/NO_CLCS.png)
We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant ... We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant blood disorders as well as the facilitation of safer and more accessible organ transplantations. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0999 | -16.6527754626 | 0.5999 | 0.6 | 0.241225 | 37235 | 0.51593637 | CS |
4 | 0.217 | 76.6784452297 | 0.283 | 0.625 | 0.24 | 23813 | 0.41741703 | CS |
12 | -0.04 | -7.40740740741 | 0.54 | 0.8401 | 0.24 | 20247 | 0.42265522 | CS |
26 | 0.12 | 31.5789473684 | 0.38 | 0.8401 | 0.139 | 20628 | 0.40811455 | CS |
52 | 0.04 | 8.69565217391 | 0.46 | 0.8401 | 0.0002 | 17396 | 0.40844268 | CS |
156 | -0.5 | -50 | 1 | 1.5 | 0.0002 | 13950 | 0.44695819 | CS |
260 | -0.14 | -21.875 | 0.64 | 2.55 | 0.0002 | 10045 | 0.73062228 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約